The role of stem cell transplantation in paediatric patients with chronic myeloid leukaemia in the era of tyrosine kinase inhibitors

被引：0
|
作者：
Suttorp, M.
Tauer, J. T.
von Neuhoff, N.
Nowasz, C.
Bradtke, J.
Teigler-Schlegel, A.
Thiede, C.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [21] A Limited But Necessary Indication of Stem Cell Transplantation for Chronic Myelogeneous Leukemia in the Era of Tyrosine Kinase Inhibitors
    Imataki, Osamu
    TRANSPLANTATION, 2014, 97 (01) : E4 - E5
  • [22] Quality of life in chronic myeloid leukaemia patients after haematopoietic cell transplantation pretreated with second-generation tyrosine kinase inhibitors
    Piekarska, Agnieszka
    Gil, Lidia
    Jakitowicz, Karolina
    Prejzner, Witold
    Komarnicki, Mieczyslaw
    Hellmann, Andrzej
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (05): : 414 - 417
  • [23] Incidence of cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors
    Casavecchia, Grazia
    Spinosa, Giuseppina
    De Gennaro, Luisa
    Zicchino, Stefano
    Gravina, Matteo
    Magnesa, Michele
    Di Biase, Matteo
    Brunetti, Natale Daniele
    ACTA CARDIOLOGICA, 2022, 77 (02) : 130 - 135
  • [24] Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors
    Coetzee, Marius J.
    Louw, Vernon J.
    Gartrell, Kevin
    Viljoen, Chris D.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2009, 99 (12): : 870 - 871
  • [25] Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
    Gale, Robert Peter
    Goldman, John M.
    ACTA HAEMATOLOGICA, 2013, 130 (03) : 192 - 195
  • [26] Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia in the Age of Tyrosine Kinase Inhibitors
    Copelan, Edward A.
    Grunwald, Michael R.
    Ghosh, Nilanjan
    Plesca, Dragos
    Trivedi, Jigar
    Avalos, Belinda R.
    DISCOVERY MEDICINE, 2015, 19 (104) : 213 - 218
  • [27] Chronic myeloid leukemia in renal transplantation patients in the era of tyrosine kinase inhibitors: A case report and review of the literature
    Murt, Ahmet
    Bayram, Batuhan
    Yilmaz, Umut
    Seyahi, Nurhan
    Eskazan, Ahmet Emre
    NEPHRON, 2024, 148 (08) : 563 - 568
  • [28] Balancing Benefits and Risk During Treatment of Paediatric Patients (pts) with Chronic Myeloid Leukaemia (CML) by Tyrosine Kinase Inhibitors (TKI)
    Suttorp, M.
    Tauer, J. T.
    Jaeger, B. A. S.
    Rosen-Wolff, A.
    KLINISCHE PADIATRIE, 2011, 223 (01): : 46 - 46
  • [29] Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
    Gianantonio Rosti
    Fausto Castagnetti
    Gabriele Gugliotta
    Michele Baccarani
    Nature Reviews Clinical Oncology, 2017, 14 : 141 - 154
  • [30] Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease
    Leong, Darryl
    Aghel, Nazanin
    Hillis, Christopher
    Siegal, Deborah
    Karampatos, Sarah
    Rangarajan, Sumathy
    Pond, Gregory
    Seow, Hsien
    HEART, 2021, 107 (08) : 667 - 673
12345